(VIANEWS) – Shares of HOFSETH BIOCARE (Oslo Børs Benchmark Index_GI: HBC.OL) jumped by a staggering 22.87% in 5 sessions from kr2.58 to kr3.17 at 17:37 EST on Wednesday, after four successive sessions in a row of gains. Oslo Børs Benchmark Index_GI is jumping 0.48% to kr1,215.64, following the last session’s upward trend.
HOFSETH BIOCARE’s last close was kr3.16, 38.04% below its 52-week high of kr5.10.
About HOFSETH BIOCARE
Hofseth BioCare ASA operates as a consumer and pet health ingredient supplier in Norway and internationally. Its products include Brilliant salmon oil; OmeGo salmon oil for the maintenance of healthy cholesterol, joint, eye, brain, and cardiovascular function; ProGo, a salmon protein hydrolysate powder for treatment of irondeficiency anaemia, irritable bowel syndrome, and sarcopenia; CalGo, a marine calcium powder produced to support cartilage function, joint health, and bone strength; CollaGo; and PetGo, a non-soluble protein. Hofseth BioCare ASA was incorporated in 2009 and is headquartered in Ålesund, Norway.
Earnings Per Share
As for profitability, HOFSETH BIOCARE has a trailing twelve months EPS of kr-0.41.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -94.78%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 28.9%, now sitting on 120.45M for the twelve trailing months.
More news about HOFSETH BIOCARE (HBC.OL).
